The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Travere Therapeutics Inc’s current trading price is -33.14% away from its 52-week high, while its distance from the 52-week low is 109.02%. The stock’s price range for this period has been between $8.09 and $25.29 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.76 million for the day, a number notably higher than the average daily volume of 1.54 million over the last three months.
At present, Travere Therapeutics Inc (TVTX) has a stock price of $16.91. In the previous session, the stock saw a rise, peaking at $47.0 after an opening price of $16.91. The day’s lowest price was $23.0, and it closed at $17.24.
Travere Therapeutics Inc ‘s stock market performance has been somewhat erratic.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Travere Therapeutics Inc (TVTX) has experienced a quarterly decline of -16.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.50B and boasts a workforce of 385 employees.
Travere Therapeutics Inc: What Analysts Are Saying
As of right now, 11 analysts are rating Travere Therapeutics Inc as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.81, with a change in price of -2.82. Similarly, Travere Therapeutics Inc recorded 1,654,623 in trading volume during the last 100 days, posting a change of -14.29%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TVTX stands at 12.20. Similarly, the long-term debt-to-equity ratio is also 9.93.
TVTX Stock Stochastic Average
Travere Therapeutics Inc’s raw stochastic average for the past 50 days is presently 84.76%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 77.53%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 82.03% and 69.40%, respectively.
TVTX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 98.24%.However, over the last six months, we can see a stronger performance of -20.27%. Over the last 30 days, the price of TVTX has fallen by 3.55%. And in the last five days, it has surged by 9.45%.
